A detailed history of Transcend Capital Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 12,646 shares of TEVA stock, worth $227,880. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,646
Previous 12,450 1.57%
Holding current value
$227,880
Previous $175,000 17.14%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$12.78 - $17.4 $2,504 - $3,410
196 Added 1.57%
12,646 $205,000
Q1 2024

May 03, 2024

SELL
$10.67 - $14.43 $992 - $1,341
-93 Reduced 0.74%
12,450 $175,000
Q4 2023

Feb 05, 2024

BUY
$8.12 - $10.63 $12,179 - $15,945
1,500 Added 13.58%
12,543 $130,000
Q1 2023

Apr 12, 2023

SELL
$8.36 - $11.37 $15,883 - $21,603
-1,900 Reduced 14.68%
11,043 $97,000
Q4 2022

Jan 20, 2023

BUY
$7.95 - $9.48 $739 - $881
93 Added 0.72%
12,943 $0
Q1 2022

Apr 20, 2022

BUY
$7.33 - $9.39 $13,927 - $17,841
1,900 Added 17.35%
12,850 $121,000
Q4 2021

Jan 20, 2022

SELL
$7.9 - $10.19 $1,185 - $1,528
-150 Reduced 1.35%
10,950 $88,000
Q3 2021

Nov 04, 2021

SELL
$8.38 - $10.18 $4,583 - $5,568
-547 Reduced 4.7%
11,100 $104,000
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $5,415 - $6,323
547 Added 4.93%
11,647 $114,000
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $95,127 - $140,859
11,100 New
11,100 $100,000
Q2 2020

Aug 05, 2020

SELL
$8.12 - $13.12 $88,913 - $143,664
-10,950 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$6.69 - $13.45 $73,255 - $147,277
10,950 New
10,950 $98,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.